PDL BioPharma: PDL BioPharma Enters Oversold Territory
PDL BioPharma has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Read full article »
PDL BioPharma engages in intellectual property asset management and patent portfolio and related assets investment activities.
Read more